You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Cisplatin

Showing 26 - 50 of 5,020
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cholangiocarcinoma Non-resectable Trial in Chengdu (Candonilimab, Cisplatin, Gemcitabine)

Recruiting
  • Cholangiocarcinoma Non-resectable
  • Chengdu, Sichuan, China
    West China Hospital, Sichuan University
Aug 4, 2023

Oral Cavity Squamous Cell Carcinoma Trial in Yichang (Sintilimab, Radiotherapy)

Recruiting
  • Oral Cavity Squamous Cell Carcinoma
  • Yichang, Hubei, China
    Department of Medical Oncology, Central Hospital of Yichang City
Feb 18, 2023

Cisplatin Adverse Reaction Trial in Tanta (cisplatin with hydration magnesium)

Enrolling by invitation
  • Cisplatin Adverse Reaction
  • cisplatin with hydration magnesium
  • Tanta, Gharbiya, Egypt
    Mohamed Saad younis
Oct 25, 2022

Malignant Pleural Mesothelioma, Mesothelioma Trial in Tampa (Cisplatin, Methotrexate, Gemcitabine)

Active, not recruiting
Has Results
  • Malignant Pleural Mesothelioma
  • Mesothelioma
  • Cisplatin
  • +3 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jan 5, 2023

The Efficacy and Safety of Therapy Efficacy for Locally Advanced ESCC Trial in Hanzhou (Cadonilimab Combined Albumin-paclitaxel,

Recruiting
  • The Efficacy and Safety of Therapy Efficacy for Locally Advanced ESCC
  • Cadonilimab Combined Albumin-paclitaxel, Cisplatin and Fluorouracil
  • Hanzhou, Zhejiang, China
    Lulu Liu
Jul 14, 2023

Renal Insufficiency, Cis-Platinum Nephropathy Trial in Bangkok (short hydration, conventional hydration)

Recruiting
  • Renal Insufficiency
  • Cis-Platinum Nephropathy
  • short hydration
  • conventional hydration
  • Bangkok, Thailand
    Faculty of Medicine Siriraj Hospital
May 23, 2023

Esophageal Squamous Cell Cancer Trial in Beijing (Toripalimab, Paclitaxel, Cisplatin)

Recruiting
  • Esophageal Squamous Cell Cancer
  • Beijing, Beijing, China
    Beijing Cancer Hospital / Peking University Cancer Hospital
Jan 30, 2023

Nasopharyngeal Carcinoma Trial in Fuzhou (without concurrent cisplatin chemo, with concurrent cisplatin chemo)

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • without concurrent cisplatin chemotherapy
  • with concurrent cisplatin chemotherapy
  • Fuzhou, Fujian, China
    Department of radiation oncology, Fujian cancer hospital
Oct 18, 2023

Urinary Bladder Cancer Trial in Guangzhou (Neoadjuvant Toripalimab in Combination With Gemcitabine and Cisplatin)

Recruiting
  • Urinary Bladder Cancer
  • Neoadjuvant Toripalimab in Combination With Gemcitabine and Cisplatin
  • Guangzhou, Guangdong, China
    Zhujiang Hospital
Jan 6, 2023

Breast Cancer Trial in Shanghai (ABX, cisplatin, Gemcitabine, Cisplatin)

Completed
  • Breast Cancer
  • ABX, cisplatin
  • Gemcitabine, Cisplatin
  • Shanghai, China
    Fudan University Cancer Hospital
Apr 20, 2022

Locally Advanced Cervical Cancer, Gemcitabine, Chemo-radiotherapy Trial in México (Gemcitabine, Cisplatin)

Recruiting
  • Locally Advanced Cervical Cancer
  • +2 more
  • México, Ciudad De México, Mexico
    National Cancer Institute of Mexico
Nov 27, 2023

Head Neck Cancer Trial in Singapore (carboplatin,, cisplatin, gemcitabine HCl)

Active, not recruiting
  • Head and Neck Cancer
  • Singapore, Singapore
    National Cancer Centre - Singapore
Sep 27, 2022

High-grade Salivary Gland Carcinoma Trial in Seoul (nivolumab, docetaxel, cisplatin Group)

Recruiting
  • High-grade Salivary Gland Carcinoma
  • nivolumab, docetaxel, cisplatin Group
  • Seoul, Korea, Republic of
    Department of Medicine, Samsung Medical Center, Sungkyunkwan Uni
Feb 3, 2023

Genetic and Epigenetic Factors on Clinical Response and Toxicity

Recruiting
  • Non Small Cell Lung Cancer
  • +2 more
  • Cisplatin injection
  • Cairo, Egypt
    Ain Shams University
Feb 16, 2023

Squamous Cell Carcinoma of Head and Neck Trial in Hangzhou (Toripalimab)

Recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • Hangzhou, Zhejiang, China
    Department of Medical Onocology, First Affiliated Hospital of Zh
Oct 7, 2023

Biliary Tract Tumors Trial (Envafolimab plus Gemcitabine&Cisplatin, Gemcitabine&Cisplatin)

Not yet recruiting
  • Biliary Tract Neoplasms
  • (no location specified)
Jun 8, 2022

Head Neck Cancer Patients, Lean Body Mass, Body Composition Changes Trial in Odense C (DXA scan, Physical testing)

Completed
  • Head and Neck Cancer Patients
  • +2 more
  • DXA scan
  • Physical testing
  • Odense C, Southern Denmark Region, Denmark
    Odense University Hospital
May 25, 2023

Esophageal Squamous Cell Carcinoma Trial (LY01015, Fluorouracil, Cisplatin)

Not yet recruiting
  • Esophageal Squamous Cell Carcinoma
  • (no location specified)
Aug 28, 2023

Ovarian Cancer, Hyperthermic Intraperitoneal Chemo, Paclitaxel Trial in Guangzhou (Hyperthermic Intraperitoneal Paclitaxel

Recruiting
  • Ovarian Cancer
  • +2 more
  • Hyperthermic Intraperitoneal Paclitaxel Combined With Cisplatin
  • Guangzhou, Other (Non U.s.), China
    Sun Yat-sen Memorial Hospital
Nov 11, 2022

Borderline Resectable Carcinoma, Biliary Tract Cancer Trial in Washington (Durvalumab, Tremelimumab, Gemcitabine)

Not yet recruiting
  • Borderline Resectable Carcinoma
  • Biliary Tract Cancer
  • Washington, District of Columbia
    Lombardi Comprehensive Cancer Center, Georgetown University
Aug 24, 2023

Advanced Biliary Tract Cancer Trial in Guangzhou (Envofolimab, Lenvatinib, Gemcitabine)

Recruiting
  • Advanced Biliary Tract Cancer
  • Guangzhou, Guangdong, China
    The First Affiliated Hospital of Sun Yat-sen University
Oct 11, 2022

Hend and Neck Squamous Cell Carcinoma Locally Advanced Operable Trial in Guangzhou (Cetuximab, Zimberelimab, Docetaxel)

Not yet recruiting
  • Hend and Neck Squamous Cell Carcinoma Locally Advanced Operable
  • Guangzhou, Guangdong, China
    Sun Yat-sen University
Oct 24, 2023

Oral Squamous Cell Carcinoma Trial in Shanghai (Camrelizumab Plus Docetaxel and Cisplatin)

Recruiting
  • Oral Squamous Cell Carcinoma
  • Camrelizumab Plus Docetaxel and Cisplatin
  • Shanghai, Shanghai, China
    Shanghai Ninth People's Hospital affiliated to Shanghai Jiao Ton
Nov 9, 2022

Squamous Cell Carcinoma of the Skin Trial in Zhengzhou (Camrelizumab)

Not yet recruiting
  • Squamous Cell Carcinoma of the Skin
  • Zhengzhou, Henan, China
    Department of Bone and Soft Tissue ,Henan Cancer Hospital
Aug 3, 2022

Nasopharyngeal Carcinoma, Nasopharyngeal Tumors, Nasopharyngeal Diseases Trial in Guangzhou (Nimotuzumab, Cisplatin)

Recruiting
  • Nasopharyngeal Carcinoma
  • +3 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Nov 3, 2022